Skip to content
BOLUS

Signal from the log

Basecamp Research

140 M$ · Series C · United Kingdom · Biotech

Basecamp Research conçoit des médicaments à partir de modèles d'intelligence artificielle entraînés sur un atlas de gènes collectés dans plus de trente pays. Ses modèles EDEN écrivent des séquences d'ADN destinées à la thérapie cellulaire, à la thérapie génique, aux enzymes et aux peptides. Aucun candidat n'est encore en clinique.

Article

Announced on , logged by the watch of 23 September 2026.

Operation
Funding round
Announced amount
140 M$
Stage
Series C
Country
United Kingdom
Sector
Biotech

What the log says

Editorial note, in French

Sujet traité. L'article donne les sources et la position de Bolus.

The investors

Led by S32 , with NVentures , Anthology Fund , Catalio Capital Management , NATO Innovation Fund , The Rockefeller Foundation , European Tech Collective , Sovereign AI , Redalpine , True Ventures , Firebrand , River Capital , King Philanthropies , Singular , Inception Fund , PostScriptum

Read the article on this operation (in French)

Provenance
Logged on 23 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Article The operation led to an article, with its sources checked one by one.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).